Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02354131
Title Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian Cancer (AVANOVA)
Recruitment Active, not recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Nordic Society for Gynaecologic Oncology
Indications

fallopian tube cancer

peritoneum cancer

ovary epithelial cancer

Therapies

Niraparib

Bevacizumab + Niraparib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.